Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bispecific antisense oligonucleotides for dystrophin exon skipping

Bispecific antisense oligonucleotides for dystrophin exon skipping

US Patent 12331293 · Granted Jun 17, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oligonucleotide comprising an inosine for treating DMD2023
Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrop2022
Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA2021
Oligonucleotide comprising an inosine for treating DMD2021
Means and methods for counteracting muscle disorders2021
RNA modulating oligonucleotides with improved characteristics for the treatment 2021
Methods and means for efficient skipping of at least one of the following exons 2020
Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA2020
Oligonucleotide comprising an inosine for treating DMD2020
Method for efficient exon (44) skipping in duchenne muscular dystrophy and assoc2019
Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA2019
RNA modulating oligonucleotides with improved characteristics for the treatment 2019